Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern India
Introduction: The overall survival in pediatric acute lymphoblastic leukemia (ALL) ranges from 45 to 81% in India. Aggressive chemotherapy protocols like MCP841 have improved the outcome and it can be delivered with minimal supportive care. This study retrospectively analyses the clinical...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2024-12-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1788703 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850162388124303360 |
|---|---|
| author | Swarnabindu Banerjee Sanjukta Saha Dibyendu Raychaudhuri Mihir Sarkar Kalpana Datta |
| author_facet | Swarnabindu Banerjee Sanjukta Saha Dibyendu Raychaudhuri Mihir Sarkar Kalpana Datta |
| author_sort | Swarnabindu Banerjee |
| collection | DOAJ |
| description |
Introduction: The overall survival in pediatric acute lymphoblastic leukemia (ALL) ranges from 45 to 81% in India. Aggressive chemotherapy protocols like MCP841 have improved the outcome and it can be delivered with minimal supportive care. This study retrospectively analyses the clinical profile and overall survival of patients treated by this protocol. |
| format | Article |
| id | doaj-art-ee0cc3693cd6477f8bd5982999b2b6b9 |
| institution | OA Journals |
| issn | 0971-5851 0975-2129 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-ee0cc3693cd6477f8bd5982999b2b6b92025-08-20T02:22:34ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292024-12-01450650951410.1055/s-0044-1788703Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern IndiaSwarnabindu Banerjee0Sanjukta Saha1Dibyendu Raychaudhuri2https://orcid.org/0000-0002-1785-1026Mihir Sarkar3Kalpana Datta4Department of Medical Oncology, Medical College and Hospital, Kolkata, IndiaDepartment of Paediatrics, Medical College and hospital, Kolkata, IndiaDepartment of Paediatrics, Medical College and hospital, Kolkata, IndiaDepartment of Paediatrics, Medical College and hospital, Kolkata, IndiaDepartment of Paediatrics, Medical College and hospital, Kolkata, India Introduction: The overall survival in pediatric acute lymphoblastic leukemia (ALL) ranges from 45 to 81% in India. Aggressive chemotherapy protocols like MCP841 have improved the outcome and it can be delivered with minimal supportive care. This study retrospectively analyses the clinical profile and overall survival of patients treated by this protocol.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1788703acute lymphoblastic leukemiahigh-dose cytarabineMCP841 protocolretrospective studysurvival analysis |
| spellingShingle | Swarnabindu Banerjee Sanjukta Saha Dibyendu Raychaudhuri Mihir Sarkar Kalpana Datta Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern India Indian Journal of Medical and Paediatric Oncology acute lymphoblastic leukemia high-dose cytarabine MCP841 protocol retrospective study survival analysis |
| title | Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern India |
| title_full | Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern India |
| title_fullStr | Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern India |
| title_full_unstemmed | Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern India |
| title_short | Clinical Profile, Toxicities, and Survival Outcome of MCP841 in Pediatric Acute Lymphoblastic Leukemia in Current Era: A Retrospective Study from Eastern India |
| title_sort | clinical profile toxicities and survival outcome of mcp841 in pediatric acute lymphoblastic leukemia in current era a retrospective study from eastern india |
| topic | acute lymphoblastic leukemia high-dose cytarabine MCP841 protocol retrospective study survival analysis |
| url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1788703 |
| work_keys_str_mv | AT swarnabindubanerjee clinicalprofiletoxicitiesandsurvivaloutcomeofmcp841inpediatricacutelymphoblasticleukemiaincurrenteraaretrospectivestudyfromeasternindia AT sanjuktasaha clinicalprofiletoxicitiesandsurvivaloutcomeofmcp841inpediatricacutelymphoblasticleukemiaincurrenteraaretrospectivestudyfromeasternindia AT dibyenduraychaudhuri clinicalprofiletoxicitiesandsurvivaloutcomeofmcp841inpediatricacutelymphoblasticleukemiaincurrenteraaretrospectivestudyfromeasternindia AT mihirsarkar clinicalprofiletoxicitiesandsurvivaloutcomeofmcp841inpediatricacutelymphoblasticleukemiaincurrenteraaretrospectivestudyfromeasternindia AT kalpanadatta clinicalprofiletoxicitiesandsurvivaloutcomeofmcp841inpediatricacutelymphoblasticleukemiaincurrenteraaretrospectivestudyfromeasternindia |